Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Receptor-positive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07427394
What this trial is testing

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 24
Early research (Phase 1)Study completedNCT03916744
What this trial is testing

Giredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
Genentech, Inc. 75
Not applicableStudy completedNCT03726931
What this trial is testing

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET

Who this might be right for
Breast Cancer
Amsterdam UMC, location VUmc 40
Not applicableStudy completedNCT00965939
What this trial is testing

An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients

Who this might be right for
ER-positive Breast Cancer
Vlaamse Vereniging voor Obstetrie en Gynaecologie 300
Testing effectiveness (Phase 2)Looking for participantsNCT06953882
What this trial is testing

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

Who this might be right for
HER2 Negative Breast Cancer
Yale University 140
Large-scale testing (Phase 3)Active Not RecruitingNCT01674140
What this trial is testing

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 1,939
Early research (Phase 1)Study completedNCT01846091
What this trial is testing

Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell Carcinoma+8 more
Mayo Clinic 12
Not applicableStudy completedNCT01208779
What this trial is testing

Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Hormon Receptor Positive Breast Cancer
AstraZeneca 90
Testing effectiveness (Phase 2)Study completedNCT05054374
What this trial is testing

Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IVHER2-negative Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00856050
What this trial is testing

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Dana-Farber Cancer Institute 27
Early research (Phase 1)Active Not RecruitingNCT04288089
What this trial is testing

H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

Who this might be right for
Receptors, EstrogenGenes, Erbb-2Breast Neoplasms
Eisai Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT00131924
What this trial is testing

High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

Who this might be right for
Breast Cancer
Northwestern University 1
Testing effectiveness (Phase 2)Study completedNCT00305825
What this trial is testing

Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery

Who this might be right for
Breast Cancer
University of California, San Francisco 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06008158
What this trial is testing

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Estrogen Receptor-Positive Breast Carcinoma+1 more
City of Hope Medical Center 48
Testing effectiveness (Phase 2)Study completedNCT00602043
What this trial is testing

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast Cancer+2 more
National Cancer Institute (NCI) 20
Large-scale testing (Phase 3)Study completedNCT00556374
What this trial is testing

Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy

Who this might be right for
Breast Cancer
Amgen 3,420
Large-scale testing (Phase 3)Study completedNCT00863655
What this trial is testing

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 724
Large-scale testing (Phase 3)Looking for participantsNCT02535221
What this trial is testing

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Who this might be right for
Breast Cancer
Peking University 234
Testing effectiveness (Phase 2)Study completedNCT02015559
What this trial is testing

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerOral Complications+5 more
Jonsson Comprehensive Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00050141
What this trial is testing

Study of Letrozole Plus Tipifarnib or Placebo in the Treatment of Advanced Breast Cancer

Who this might be right for
Breast Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 121
Next Page